NU-RISE is a medical company that develops nuclear radiation sensors and equipment for cancer treatment.
NU-RISE has raised $3.5M in total funding. The most recent round was Seed. The last funding was announced in March 2023.
NU-RISE's investors include MassChallenge, Portugal Ventures, Caixa Capital, GED Ventures Portugal, maze impact.
NU-RISE is headquartered in Aveiro, Portugal.
NU-RISE is a medical company that develops nuclear radiation sensors and equipment for cancer treatment.
NU-RISE is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"NU-RISE — Funding & Investors." VCBacked, March 4, 2023, https://www.vcbacked.co/company/nu-rise. Accessed July 20, 2026.
VCBacked. (2023). NU-RISE — Funding & Investors. Retrieved July 20, 2026, from https://www.vcbacked.co/company/nu-rise
{{cite web |title=NU-RISE — Funding & Investors |url=https://www.vcbacked.co/company/nu-rise |website=VCBacked |access-date=July 20, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated